124 related articles for article (PubMed ID: 15638990)
21. Expression of a bioactive recombinant human interleukin-11 in chicken HD11 cell line.
Léon A; Wang XM; Champion-Arnaud P; Sobczyk A; Pain B; Content J; Jacques Y; Valarché I
Cytokine; 2005 Jun; 30(6):382-90. PubMed ID: 15869884
[TBL] [Abstract][Full Text] [Related]
22. Preformulation stability screening of ivermectin with non-ionic emulsion excipients.
Shaw NO; de Villiers MM; Lötter AP
Pharmazie; 1999 May; 54(5):372-6. PubMed ID: 10368831
[TBL] [Abstract][Full Text] [Related]
23. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
Kristensen S; Lao YE; Brustugun J; Braenden JU
Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
[TBL] [Abstract][Full Text] [Related]
24. Effect of rhIL-2 in inhalant form on experimental respiratory tract infection with Klebsiella pneumoniae in mice.
Tang Y; Zhu JB; Cheng DS; Zhang XS; Zhou B; Shen HY
Yao Xue Xue Bao; 2005 Jan; 40(1):17-21. PubMed ID: 15881320
[TBL] [Abstract][Full Text] [Related]
25. Irradiation of human insulin in aqueous solution, first step towards radiosterilization.
Terryn H; Maquille A; Houée-Levin C; Tilquin B
Int J Pharm; 2007 Oct; 343(1-2):4-11. PubMed ID: 17537599
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a capillary zone electrophoresis method for assessment of recombinant human granulocyte colony-stimulating factor in pharmaceutical formulations and its correlation with liquid chromatography methods and bioassay.
Dalmora SL; D'Avila FB; da Silva LM; Bergamo AC; Zimmermann ES
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(24):2471-6. PubMed ID: 19560410
[TBL] [Abstract][Full Text] [Related]
27. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K
Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449
[TBL] [Abstract][Full Text] [Related]
28. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
[TBL] [Abstract][Full Text] [Related]
29. Formulation development and stability testing of oral morphine solution utilizing preformulation approach.
Preechagoon D; Sumyai V; Tontisirin K; Aumpon S; Pongjanyakul T
J Pharm Pharm Sci; 2005 Aug; 8(2):362-9. PubMed ID: 16124948
[TBL] [Abstract][Full Text] [Related]
30. Purification and characterization of recombinant truncated human interleukin-11 expressed as fusion protein in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Jul; 27(13):905-10. PubMed ID: 16091884
[TBL] [Abstract][Full Text] [Related]
31. A novel platform for biologically active recombinant human interleukin-13 production.
Wang DJ; Brandsma M; Yin Z; Wang A; Jevnikar AM; Ma S
Plant Biotechnol J; 2008 Jun; 6(5):504-15. PubMed ID: 18393948
[TBL] [Abstract][Full Text] [Related]
32. Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE.
Yu L; Li Y; Tao L; Jia C; Yao W; Rao C; Wang J
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925680
[TBL] [Abstract][Full Text] [Related]
33. Overproduction of human interleukin-2 in recombinant Escherichia coli BL21 high-cell-density culture by the determination and optimization of essential amino acids using a simple stoichiometric model.
Yegane-Sarkandy S; Farnoud AM; Shojaosadati SA; Khalilzadeh R; Sadeghyzadeh M; Ranjbar B; Babaeipour V
Biotechnol Appl Biochem; 2009 Jul; 54(1):31-9. PubMed ID: 19341362
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of recombinant human interleukin-2 by potassium peroxodisulfate.
Cadée JA; van Steenbergen MJ; Versluis C; Heck AJ; Underberg WJ; den Otter W; Jiskoot W; Hennink WE
Pharm Res; 2001 Oct; 18(10):1461-7. PubMed ID: 11697473
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels.
Hiemstra C; Zhong Z; Van Tomme SR; van Steenbergen MJ; Jacobs JJ; Otter WD; Hennink WE; Feijen J
J Control Release; 2007 Jun; 119(3):320-7. PubMed ID: 17475360
[TBL] [Abstract][Full Text] [Related]
36. Stability of citrated caffeine injectable solution in glass vials.
Donnelly RF; Tirona RG
Am J Hosp Pharm; 1994 Feb; 51(4):512-4. PubMed ID: 8017419
[No Abstract] [Full Text] [Related]
37. New analytical techniques to facilitate preformulation screening in propellant systems.
Mogalian E; Kuehl PJ; Myrdal PB
Int J Pharm; 2007 Aug; 340(1-2):223-9. PubMed ID: 17498897
[TBL] [Abstract][Full Text] [Related]
38. Skin permeation and stability studies of 5-aminolevulinic acid in a new gel and patch preparation.
Valenta C; Auner BG; Loibl I
J Control Release; 2005 Oct; 107(3):495-501. PubMed ID: 16087267
[TBL] [Abstract][Full Text] [Related]
39. Stability of amlodipine besylate and atenolol in multi-component tablets of mono-layer and bi-layer types.
Aryal S; Skalko-Basnet N
Acta Pharm; 2008 Sep; 58(3):299-308. PubMed ID: 19103566
[TBL] [Abstract][Full Text] [Related]
40. Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of recombinant human erythropoietin (r-HuEPO) aggregates.
Gunturi SR; Ghobrial I; Sharma B
J Pharm Biomed Anal; 2007 Jan; 43(1):213-21. PubMed ID: 16875794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
